Joseph Cappello

Dr. Cappello has served as Genelux Corporation’s Vice President of Pharmaceutical Development since November 2012 and General Manager of Genelux CMF (Commercial Manufacturing Facility) since September 2018. Over three decades, Dr. Cappello’s career has spanned pharmaceutical and medical device development, R&D, regulatory affairs, GMP manufacturing, clinical study design and management and academic research.

In 1988, Dr. Cappello co-founded the start-up biotechnology company Protein Polymer Technologies Inc., based on technology he co-invented, which later transitioned to a public company. In his role as Vice President, Research and Development and Chief Technology Officer (CTO), he conducted R&D, product development, GMP manufacturing and clinical development, managing multiple multi-center clinical trials. In 2010, he became an adjunct Professor of Pharmaceutical Sciences at the University of Utah with research interests in matrix assisted drug delivery using bioabsorbable materials, a position which he retains today. He served previously as Director/General Manager of the Biological Test Center for B. Braun Medical, Inc., where he managed a GLP/GMP organization conducting safety and analytical studies for new pharmaceutical development.

Over his career, Dr. Cappello has authored more than 70 scientific publications in peer reviewed journals and holds 19 U.S. Patents. Dr. Cappello earned his Ph.D. in Biological Chemistry from the University of Cincinnati, College of Medicine, and his B.S. in Molecular and General Genetics from the University of California, Davis.